Page 84 - Michael Erman News Today

RPT-Georgia among first U.S. states to provide COVID-19 shots to kids under 16 Reuters 5/11/2021 (Repeats to wider audience with no changes) By Rich McKay and Carl ODonnell ATLANTA, May 11 (Reuters) - When the state of Georgia made COVID-19 vaccinations available to children as young as 12 on Tuesday, Atlanta residents Jenny and Jeffrey Brower rushed to schedule an appointment for their twin 13-year-old girls. As Georgians, they were among the lucky ones. Providers in their state, along with ...

WASHINGTON (Reuters) — U.S. regulators authorized Pfizer and BioNTechs COVID-19 vaccine for use in children as young as 12 and said they could begin receiving shots as soon as Thursday, widening the countrys inoculation program as vaccination rates have slowed significantly. This is the first COVID-19 vaccine to be authorized in the United States for ages 12 to 15. Vaccinating younger ages is considered an important step for getting children back into schools safely. U.S. President Joe Biden ...

U.S. authorizes Pfizer/BioNTech COVID vaccine for children 12 to 15 The vaccine has been available under an emergency use authorization (EUA) to people as young as 16 in the United States. The vaccine makers said they had started the process for full approval for those ages last week. Written By: Michael Erman / Reuters | 4:27 pm, May 10, 2021 × A healthcare worker prepares a dose of the Pfizer/BioNTech coronavirus disease (COVID-19) vaccine, which was authorized by Canad...

Publishing date: May 07, 2021  •  6 hours ago  •  3 minute read  •  Article content U.S. support for waiving intellectual property rights on COVID-19 vaccines could be a tactic to convince drugmakers to back less drastic steps like sharing technology and expanding joint ventures to quickly boost global production, lawyers said on Thursday. “I think the end result that most players are looking for here is not IP waiver in particular, it’s expanded global access to the vaccines...

By Syndicated Content By Michael Erman and Blake Brittain (Reuters) – U.S. support for waiving intellectual property rights on COVID-19 vaccines could be a tactic to convince drugmakers to back less drastic steps like sharing technology and expanding joint ventures to quickly boost global production, lawyers said on Thursday. “I think the end result that most players are looking for here is not IP waiver in particular, it’s expanded global access to the vaccines,” said Profe...

By Syndicated Content By Allison Martell and Euan Rocha (Reuters) – To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots. As a result, the U.S. government laid claim not only to vast quantities of finished COVID-19 vaccines but also to vaccine components and equipment all along the supply chain, according to a Reuters review of more than a dozen contracts involving some major supplie...

Fri, 7th May 2021 16:00 By Allison Martell and Euan Rocha May 7 (Reuters) - To fight the pandemic at home, the United States gave its own vaccine manufacturers priority access to American-made materials needed to make the shots. As a result, the U.S. government laid claim not only to vast quantities of finished COVID-19 vaccines but also to vaccine components and equipment all along the supply chain, according to a Reuters review of more than a dozen contracts involving some major suppliers. su...

U.S. backs giving poorer countries access to COVID-19 vaccine patents, reversing stance By Andrea Shalal, Jeff Mason and David Lawder Reuters WASHINGTON (Reuters) -President Joe Biden on Wednesday threw his support behind waiving intellectual property rights for COVID-19 vaccines, bowing to mounting pressure from Democratic lawmakers and more than 100 other countries, but angering pharmaceutical companies. Biden voiced his support for a waiver - a sharp reversal of the previous U.S. position - ...

5/5/2021 By Andrea Shalal, Jeff Mason and David Lawder WASHINGTON, May 5 (Reuters) - President Joe Biden on Wednesday threw his support behind waiving intellectual property rights for COVID-19 vaccines, bowing to mounting pressure from Democratic lawmakers and more than 100 other countries, but angering pharmaceutical companies. Biden voiced his support for a waiver - a sharp reversal of the previous U.S. position - in remarks to reporters, followed swiftly by a statement from his top trade neg...

Biden Backs Patent Waiver for Covid-19 Vaccines President Joe Biden on Wednesday threw his support behind waiving intellectual property rights for COVID-19 vaccines, bowing to mounting pressure from Democratic lawmakers and more than 100 other countries, but angering pharmaceutical companies. Biden voiced his support for a temporary waiver – a sharp reversal of the previous U.S. position – after a speech at the White House, followed swiftly by an official statement from his chief trade nego...